Clinical Trial Update: Ketamine for the Treatment of Depression in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of ketamine for depression in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Parkinson Disease

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Yale University | Conditions: Parkinson's Disease, Depression | Phase 2 | Status: COMPLETED